A comparative study of the hypolipidemic effects and mechanisms of action of Laminaria japonica - and Ascophyllum nodosum -derived fucoidans in apolipoprotein E-deficient mice
Tian Liu,Xue Wang,Yan-Ming Wang,Feng-Rong Sui,Xue-Ying Zhang,Hai-Di Liu,Dong-Yue Ma,Xiao-Xiao Liu,Shou-Dong Guo
DOI: https://doi.org/10.1039/d3fo05521c
IF: 6.3173
2024-05-15
Food & Function
Abstract:The structural characteristics of fucoidans exhibit species and regional diversity. Previous studies have demonstrated that Laminaria japonica - and Ascophyllum nodosum -derived fucoidans have type I and type II fucosyl chains, respectively. These chemical differences may contribute to distinct hypolipidemic effects and mechanisms of action. Chemical analysis demonstrated that the percentage contents of sulfate, glucuronic acid, and galactose were higher in L. japonica -derived fucoidans than those of A. nodosum -derived fucoidans. In hyperlipidemic apolipoprotein E-deficient mice, both A. nodosum - and L. japonica -derived fucoidans significantly decreased the plasma and hepatic levels of total cholesterol and triglyceride, leading to the reduction of atherosclerotic plaques. Western blotting experiments demonstrated that these fucoidans significantly enhanced the expression and levels of scavenger receptor B type 1, cholesterol 7 alpha-hydroxylase A1, and peroxisome proliferator-activated receptor (PPAR)-α, contributing to circulating lipoprotein clearance and fatty acid degradation, respectively. Differentially, L. japonica -derived fucoidan significantly increased the LXR/ATP-binding cassette G8 signaling pathway in the small intestine, as revealed by real-time quantitative PCR, which may lead to further cholesterol and other lipid excretion. Collectively, these data are useful for understanding the hypolipidemic mechanisms of action of seaweed-derived fucoidans, and their potential application for the prevention and/or treatment of atherosclerotic cardiovascular diseases.
biochemistry & molecular biology,food science & technology